PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH was reported 56 times

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROTEIN S INCREASED 1 0.0357
1 CRYOTHERAPY 1 0.0135
2 MEAN PLATELET VOLUME ABNORMAL 1 0.0125
3 RENAL CELL CARCINOMA RECURRENT 1 0.0079
4 TESTICULAR FAILURE 1 0.0073
5 RED CELL DISTRIBUTION WIDTH ABNORMAL 1 0.0053
6 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 1 0.0044
7 HYDROURETER 1 0.0026
8 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
9 BLOOD CREATINE ABNORMAL 1 0.0021
10 CORTISOL INCREASED 1 0.0016
11 EOSINOPHIL COUNT ABNORMAL 1 0.0013
12 TRACHEITIS 1 0.0013
13 CREATINE KINASE INCREASED 1 0.0013
14 BLADDER CATHETERISATION 1 0.0010
15 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
16 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0009
17 HAEMATOCRIT ABNORMAL 1 0.0008
18 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
19 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
20 GENERALISED ANXIETY DISORDER 1 0.0007
21 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
22 OXYGEN THERAPY 1 0.0006
23 INJECTION RELATED REACTION 1 0.0006
24 THERAPY CHANGE 4 0.0004
25 AORTIC ARTERIOSCLEROSIS 1 0.0004
26 ORAL FUNGAL INFECTION 1 0.0004
27 NEUTROPHIL COUNT ABNORMAL 1 0.0004
28 RESPIRATORY SYMPTOM 1 0.0004
29 GRANULOMA 1 0.0003
30 HYPERTRANSAMINASAEMIA 2 0.0003
31 CAROTID ARTERY OCCLUSION 1 0.0003
32 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
33 MUSCLE FATIGUE 1 0.0002
34 AUTOIMMUNE DISORDER 2 0.0002
35 ENERGY INCREASED 1 0.0002
36 ADRENAL INSUFFICIENCY 2 0.0002
37 GENERALISED OEDEMA 2 0.0002
38 HAEMOGLOBIN ABNORMAL 1 0.0002
39 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
40 BRONCHIECTASIS 1 0.0001
41 HYPERTHYROIDISM 2 0.0001
42 MAJOR DEPRESSION 1 0.0001
43 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
44 ATRIOVENTRICULAR BLOCK 1 0.0001
45 MYASTHENIA GRAVIS 1 0.0001
46 MYOSITIS 1 0.0001
47 PRODUCT DISTRIBUTION ISSUE 1 0.0001
48 EYELID PTOSIS 1 0.0001
49 DRY THROAT 1 0.0001
50 MYOCARDITIS 1 0.0001
51 POST PROCEDURAL HAEMORRHAGE 1 0.0001
52 HYPERCALCAEMIA 1 0.0001
53 PARAESTHESIA ORAL 1 0.0001
54 HYPOAESTHESIA ORAL 1 0.0001
55 HYPOTHYROIDISM 2 0.0001
56 GAIT INABILITY 2 0.0001
57 ISCHAEMIC STROKE 1 0.0001
58 HYPERGLYCAEMIA 2 0.0001
59 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
60 BLOOD GLUCOSE ABNORMAL 1 0.0001
61 RHABDOMYOLYSIS 2 0.0000
62 RETCHING 1 0.0000
63 LIVER FUNCTION TEST INCREASED 1 0.0000
64 HEART RATE IRREGULAR 1 0.0000
65 INJECTION SITE URTICARIA 1 0.0000
66 ENCEPHALOPATHY 1 0.0000
67 UNRESPONSIVE TO STIMULI 1 0.0000
68 MUSCULOSKELETAL PAIN 2 0.0000
69 EAR INFECTION 1 0.0000
70 THROAT TIGHTNESS 1 0.0000
71 SKIN LESION 1 0.0000
72 RESPIRATORY DISTRESS 1 0.0000
73 INTENTIONAL DOSE OMISSION 1 0.0000
74 HERPES ZOSTER 2 0.0000
75 LABORATORY TEST ABNORMAL 1 0.0000
76 INJECTION SITE RASH 1 0.0000
77 INJECTION SITE ERYTHEMA 4 0.0000
78 SWOLLEN TONGUE 1 0.0000
79 MOVEMENT DISORDER 1 0.0000
80 INJECTION SITE PRURITUS 2 0.0000
81 DYSARTHRIA 1 0.0000
82 DRY MOUTH 2 0.0000
83 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
84 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
85 DYSPHAGIA 2 0.0000
86 HYPOGLYCAEMIA 1 0.0000
87 DRY EYE 1 0.0000
88 CELLULITIS 1 0.0000
89 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
90 BRADYCARDIA 1 0.0000
91 ANAPHYLACTIC REACTION 1 0.0000
92 HYPONATRAEMIA 1 0.0000
93 FLATULENCE 1 0.0000
94 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
95 DYSPHONIA 1 0.0000
96 NO ADVERSE EVENT 3 0.0000
97 PLEURAL EFFUSION 1 0.0000
98 PRODUCT USE ISSUE 3 0.0000
99 AMNESIA 1 0.0000
100 DYSGEUSIA 1 0.0000
101 INJECTION SITE SWELLING 1 0.0000
102 ARTHRITIS 1 0.0000
103 MYALGIA 2 0.0000
104 BALANCE DISORDER 1 0.0000
105 MUSCULOSKELETAL STIFFNESS 1 0.0000
106 ADVERSE DRUG REACTION 1 0.0000
107 PULMONARY EMBOLISM 1 0.0000
108 NEUROPATHY PERIPHERAL 1 0.0000
109 INJECTION SITE PAIN 3 0.0000
110 CHILLS 1 0.0000
111 OEDEMA PERIPHERAL 1 0.0000
112 VISUAL IMPAIRMENT 1 0.0000
113 PRURITUS 3 0.0000
114 PSORIASIS 1 0.0000
115 RENAL FAILURE 1 0.0000
116 DEHYDRATION 1 0.0000
117 ARTHRALGIA 3 0.0000
118 COUGH 2 0.0000
119 RASH 3 0.0000
120 PAIN IN EXTREMITY 2 0.0000
121 HYPOAESTHESIA 1 0.0000
122 HOSPITALISATION 1 0.0000
123 FATIGUE 5 0.0000
124 PARAESTHESIA 1 0.0000
125 CEREBROVASCULAR ACCIDENT 1 0.0000
126 URINARY TRACT INFECTION 1 0.0000
127 CHEST PAIN 1 0.0000
128 ASTHENIA 2 0.0000
129 BLOOD GLUCOSE INCREASED 1 0.0000
130 PAIN 3 0.0000
131 HYPERTENSION 1 0.0000
132 WEIGHT DECREASED 1 0.0000
133 DIARRHOEA 2 0.0000
134 PNEUMONIA 1 0.0000
135 DIZZINESS 1 0.0000
136 HEADACHE 1 0.0000
137 NAUSEA 1 0.0000